Antisoma Share Discussion Threads

[cestnous] 23/5/2008 14:12

Well we seem to have had a double top followed by a double bottom at the moment. So what does that presage I wonder?

[skyship] 23/5/2008 13:53

Long @ 26.7p - like the chart. Displays good base-building; and if the recent deal justifies a 26p placing price then there has to be a medium term (less than 12months) 20%/25% upside from here. Personal target is for the 38p/40p level achieved last October. That would of course deliver 50%!

[bluechef] 23/5/2008 08:21

Second that scruff, and a healthy one!

[scruff1] 22/5/2008 19:05

Well it's done now and we ain't been hit too much. Maybe we can now start a steady rise on prospects and hopefully good news. Only future I want for ASM is a wealthy one

[tim the trout] 22/5/2008 09:43

Cheers bluechef.
I think the empire must grow or get eaten.
Depends on what kind of future you want for ASM.

[bluechef] 22/5/2008 08:08

We know about the share issue gnomet, taking that into account. The nous is there mate.

[gnomet2] 22/5/2008 04:11

Well done, scruff - glad to see someone with a bit of nous on the thread.
Bit of a dead thread with just the odd cheerleading comments.
A share issue rather flagged since last year and I'm actually relieved that that it wasn't heavily discounted - dunno about you but I'd rather they kept their hands out of their ( our!) wallets and stopped empire building from now on.
I'm a bit uneasy about prostate results in couple of months, but confident about 1411 aml ones at least the second leg higher dose ones, think good value
though share price possibly held back by issue price for time being. I stay firm holder medium term. (FWTW)
Tim .. similar with all our biotechs, and I wouldn't count on the market getting it all wrong.

[scruff1] 21/5/2008 17:53

Issue of more shares - dilution.

[bluechef] 21/5/2008 15:34

Tim same boat as you, ive no idea. Every time we get positive news we rise slightly, followed by a sharp pull back. There is risk yes but with all its got going for it 30p should be smashed.

[tim the trout] 21/5/2008 14:21

IMO there has been a lot of good news and positive data but I fail to understand why can't ASM breach 30p?



The 5 analysts offering 12 month price targets for Antisoma (ASM:LSE) have a median target of 60.00, with a high estimate of 85.00 and a low estimate of 40.00. The median estimate represents a 114.29% increase from the last price of 28.00.

Any ideas?

[themajor7] 19/5/2008 19:07

watch ..reme//fly tomorrow.

[cestnous] 19/5/2008 08:41

Write up in FT over the weekend, nothing new but at least its exposure.

[davenic] 18/5/2008 12:32

Lets hope so Scruff all building up nicely

[scruff1] 18/5/2008 08:15

Mind if I join in Dave? Don't like to see you talking to yourself. I wouldn't expect the presentation to do anything for the share price They never have done before - just routine. I'm surprised the Xanthus deal hasn't attracted more debate on here though. It seems an exciting move to me and could help us tick up.

[davenic] 16/5/2008 12:27

Just need to clear 30p this afternoon then hopefully next stop 40p

[davenic] 16/5/2008 12:14

Nice to see them doing the rounds again too

16 May 2008, London, UK: Antisoma plc (LSE: ASM; USOTC: ATSMY)
announces that its Chief Executive, Glyn Edwards, will be presenting
at Rodman & Renshaw 5th Annual Global Healthcare Conference in Monte
Carlo, Monaco.

The presentation is scheduled for 12:50 CET (11:50 BST) on Monday,
May 19th, and a webcast will be available on Antisoma's website at


For live viewing of the webcast, it is recommended that viewers log
on 15 minutes early in order to register and download any necessary
software.

[davenic] 16/5/2008 11:12

Market likes by the look of it after the web cast I expect to see more action

[bluechef] 16/5/2008 09:33

This bit is a bit concerning, not sure how the market will react.

Cudden said the combined company's cashburn rate, around 30 million pounds
per year over the next two year, is high, but it likely to generate positive
data on its lead product and attract more milestone payments from Novartis.

[davenic] 16/5/2008 08:46

This bit I liked "Glyn Edwards, Antisoma CEO, said: "This is a transforming deal"


I think we will be looking at a very healthy rise today

[zagrem] 16/5/2008 08:34

Interesting at least, spike in s.p.....for now!

[gnomet2] 02/5/2008 15:20

I think the market is betting on decent as1411 phase II results this quarter, in
line with what I said in my previous post.

[davenic] 02/5/2008 12:02

All looking good I think people are starting to realise the potential here & news flow has been very good

[divestor] 02/5/2008 11:27

Is an IC tip not the kiss of death? For any techies out there - interesting to see a clear prediction of this movement for once, and no I did not act on it.